ABCB1 and central nervous system cancer: In this study, we proposed ABCB1 methylation as a new valuable DNA methylation-based biomarker to stratify glioma patients according to the aggressiveness of the tumor, and to facilitate an accurate diagnosis and prognosis of gliomas.